BioLight Life Sciences Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was ILS 0.118 million compared to ILS 0.063 million a year ago. Net loss was ILS 26.02 million compared to ILS 7.85 million a year ago.

Basic loss per share from continuing operations was ILS 5.6 compared to ILS 1.72 a year ago. Diluted loss per share from continuing operations was ILS 5.6 compared to ILS 1.72 a year ago.